| Names | |
|---|---|
| IUPAC name 5-(8-Ethynyl-6-pyridin-2-yl-4H-imidazo[1,5-a][1,4]benzodiazepin-3-yl)-1,3-oxazole | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
| |
| |
| Properties | |
| C21H13N5O | |
| Molar mass | 351.369 g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
KRM-II-81 is apositive allosteric modulator of the GABAA receptor. It is selective for thealpha2 andalpha3 subunits. KRM-II-81 displaysanxiolytic,antidepressant andanticonvulsant effects. However, it has less adverse effects than some otherGABAA PAMs: it has low to no sedation and no tolerance development.[2]
A study has also shown KRM-II-81 to be better at treating seizures than diazepam.[3]
Thisanticonvulsant-related article is astub. You can help Wikipedia byexpanding it. |